Detalhe da pesquisa
1.
Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + ß-blocker for prevention of variceal rebleeding.
Hepatology
; 63(2): 581-9, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26517576
2.
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
Gut
; 63(1): 72-9, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23135759
3.
Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up.
PLoS One
; 11(4): e0142481, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27099937
4.
Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.
Inflamm Bowel Dis
; 21(2): 369-77, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25569738
5.
Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy.
J Crohns Colitis
; 9(11): 1016-23, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26254056
6.
Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.
J Crohns Colitis
; 8(7): 590-7, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24351733
7.
Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
Inflamm Bowel Dis
; 20(4): 637-45, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24518606